Abstract: The present invention provides a medical device containing a cake composition comprising aripiprazole as an active ingredient and capable of suppressing agglomeration of aripiprazole in a suspension obtained by resuspending a freeze-dried substance; and a cake composition comprising aripiprazole as an active ingredient. The present invention relates to a medical device containing, in a storage container whose inner wall is treated with silicone, a freeze-dried cake composition comprising separately prepared aripiprazole as an active ingredient, wherein there is a space between the inner wall and the cake composition; and a cake composition comprising aripiprazole as an active ingredient and having a strength of 5 to 100 N.

Abstract: The present invention provides a medical device containing a cake composition comprising aripiprazole as an active ingredient and capable of suppressing agglomeration of aripiprazole in a suspension obtained by resuspending a freeze-dried substance; and a cake composition comprising aripiprazole as an active ingredient. The present invention relates to a medical device containing, in a storage container whose inner wall is treated with silicone, a freeze-dried cake composition comprising separately prepared aripiprazole as an active ingredient, wherein there is a space between the inner wall and the cake composition; and a cake composition comprising aripiprazole as an active ingredient and having a strength of 5 to 100 N.

Abstract: The present invention provides a medical device containing a cake composition comprising aripiprazole as an active ingredient and capable of suppressing agglomeration of aripiprazole in a suspension obtained by resuspending a freeze-dried substance; and a cake composition comprising aripiprazole as an active ingredient. The present invention relates to a medical device containing, in a storage container whose inner wall is treated with silicone, a freeze-dried cake composition comprising separately prepared aripiprazole as an active ingredient, wherein there is a space between the inner wall and the cake composition; and a cake composition comprising aripiprazole as an active ingredient and having a strength of 5 to 100 N.

Abstract: A herbicide composition for lawn characterized by containing iodosulfuron-methyl or its salt, and at least 1 kind of herbicidal compound selected from the group consisting of oxaziclomefone, fentrazamide, oxadiargyl, ethoxysulfuron, cafenstrole, indanofan, asulam, fenoxaprop, clethodim, ethofumesate, tribenuron-methyl, metsulfuron-methyl, thifensulfuron-methyl, bromoxynil, MCPA, 2,4-D, dicamba as effective components.

Abstract: An apparatus and method suitable for producing a polymer film, particularly a polyimide film, perform drying and heat treatment using a tenter type feeding apparatus that suppresses the problems of deformation of film in the vicinity of pore into which the pins bite and breakage of the pores to form long pores in the width direction. The apparatus includes a device to suppress deformation of the film in the vicinity of the tenter pins at the time point when the both ends of the film is pierced with the pins and cools the pin temperature to less than 180° C. at the time when the film is pierced with the pins. Individual pins can be arranged on the innermost side of the pin sheets so that they are all disposed at the same distance both in the film feeding direction in the individual pin sheets and between other pin sheets.

Abstract: A herbicide composition for lawn characterized by containing iodosulfuron-methyl or its salt, and at least 1 kind of herbicidal compound selected from the group consisting of oxaziclomefone, fentrazamide, oxadiargyl, ethoxysulfuron, cafenstrole, indanofan, asulam, fenoxaprop, clethodim, ethofumesate, tribenuron-methyl, metsulfuron-methyl, thifensulfuron-methyl, bromoxynil, MCPA, 2,4-D, dicamba as effective components.

Abstract: A herbicide composition for lawn characterized by containing iodosulfuron-methyl or its salt, and at least 1 kind of herbicidal compound selected from the group consisting of oxaziclomefone, fentrazamide, oxadiargyl, ethoxysulfuron, cafenstrole, indanofan, asulam, fenoxaprop, clethodim, ethofumesate, tribenuron-methyl, metsulfuron-methyl, thifensulfuron-methyl, bromoxynil, MCPA, 2,4-D, dicamba as effective components.

Abstract: An apparatus and method suitable for producing a polymer film, particularly a polyimide film, perform drying and heat treatment using a tenter type feeding apparatus that suppresses the problems of deformation of film in the vicinity of pore into which the pins bite and breakage of the pores to form long pores in the width direction. The apparatus includes a device to suppress deformation of the film in the vicinity of the tenter pins at the time point when the both ends of the film is pierced with the pins and cools the pin temperature to less than 180° C. at the time when the film is pierced with the pins. Individual pins can be arranged on the innermost side of the pin sheets so that they are all disposed at the same distance both in the film feeding direction in the individual pin sheets and between other pin sheets.

Abstract: A package including an endless belt; a first cylindrical body contacting an inner surface of the endless belt at a first pressure; a second cylindrical body contacting another inner surface of the endless belt at a second pressure; and a third cylindrical body contacting an outer surface of the endless belt at a third pressure, wherein the endless belt is wound around the first, second and third cylindrical bodies while the first, second and third cylindrical bodies are arranged so as to be parallel to each other and substantially located in one plane, and wherein a surface of each of the first, second and third cylindrical bodies contacting the endless belt has a maximum height of from 0.8 to 150 ?m when measured by a method based on JIS B 0601.

Abstract: This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]: Wherein each symbol is as defined in the specification or salts thereof which have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.

Abstract: An electrophotographic photoreceptor, including an electroconductive substrate; a charge generation layer overlying the electroconductive substrate; and a charge transport layer overlying the charge generation layer, wherein the charge generation layer includes a phthalocyanine pigment and an asymmetric azo pigment having the following formula (I): the charge generation layer or the charge transport layer includes polyalkyleneglycol, polyalkyleneglycol ester, polyalkyleneglycol ether or crown ether.

Abstract: A package including an endless belt; a first cylindrical body contacting an inner surface of the endless belt at a first pressure; a second cylindrical body contacting another inner surface of the endless belt at a second pressure; and a third cylindrical body contacting an outer surface of the endless belt at a third pressure, wherein the endless belt is wound around the first, second and third cylindrical bodies while the first, second and third cylindrical bodies are arranged so as to be parallel to each other and substantially located in one plane, and wherein a surface of each of the first, second and third cylindrical bodies contacting the endless belt has a maximum height of from 0.8 to 150 m when measured by a method based on JIS B 0601.

Abstract: A package including an endless belt; a first cylindrical body contacting an inner surface of the endless belt at a first pressure; a second cylindrical body contacting another inner surface of the endless belt at a second pressure; and a third cylindrical body contacting an outer surface of the endless belt at a third pressure, wherein the endless belt is wound around the first, second and third cylindrical bodies while the first, second and third cylindrical bodies are arranged so as to be parallel to each other and substantially located in one plane, and wherein a surface of each of the first, second and third cylindrical bodies contacting the endless belt has a maximum height of from 0.8 to 150 ?m when measured by a method based on JIS B 0601.

Abstract: It is intended to prevent glufosinate fine granule from a change or decrease in its herbicidal effect depending on climate conditions. Glufosinate is blended with other chemicals and then an adhesion aid is added thereto. The obtained mixture is formed into fine granule. Thus, a foliage treatment technique achieving a stable herbicidal effect is provided.

Abstract: This invention relates to new aminoalcohol derivatives or salts thereof represented by the following formula [I]: wherein each symbol is as defined in the specification or salts thereof which have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.

Abstract: A compound of the formula (I): wherein X1 is bond or —OCH2—; X2 is —(CH2)n—, in which n is 1, 2 or 3; X3 is bond, —O—, —S—, —OCH2—, or —NH—; R1 is phenyl or pyridyl each of which may have one or two substituent(s) selected from the group consisting of hydroxy, halogen, etc.; R2 is hydrogen, (lower)alkoxycarbonyl, etc.; R3 is hydroxy(lower)alkyl; halo(lower)alkyl, etc.; R4 is aryl or unsaturated heterocyclic group, each of which may have one or two substituent(s) selected from the group consisting of lower alkyl, hydroxy, carbamoyl, halogen, lower alkoxy, etc.; and a salt thereof which is useful as a medicament.

Abstract: The present invention relates to a compound formula (I) wherein X1 is bond or —O—CH2—, (II) or (III) R1 is hydrogen or an amino protective group, a is phenyl, indolyl or carbazolyl, each of which may be substituted with one or two substituent(s), and B is hydrogen; halogen; lower alkyl; lower alkoxycarbonyl; cyclo(lower)alkyl; or a heterocyclic group, naphthyl, 1,2,3,4-tetrahydronaphthyl, benzyl or phenyl, each of which may be substituted with one or two substituent(s), or a salt thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiures or urinary incontinence.

Abstract: The present invention relates to a compound formula wherein R1 is phenyl, pyridyl, etc., each of which may be substituted with one or two substituent(s); R2 is hydrogen, an amino protective group, etc.; R3 and R4 are each independently hydrogen, lower alkyl or hydroxy(lower)alkyl; R5 is aryl, ar(lower)alkyl, etc., each of which may be substituted with one, two or three substituent(s); R8 is hydrogen or halogen, X is a single bond or O—CH2—, and n is 0, 1 or 2, or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.

Abstract: The present invention relates to a compound formula (I) wherein X1 is bond or —O—CH2—, (II) or (III) R1 is hydrogen or an amino protective group, a is phenyl, indolyl or carbazolyl, each of which may be substituted with one or two substituent(s), and B is hydrogen; halogen; lower alkyl; lower alkoxycarbonyl; cyclo(lower)alkyl; or a heterocyclic group, naphthyl, 1,2,3,4-tetrahydronaphthyl, benzyl or phenyl, each of which may be substituted with one or two substituent(s), or a salt thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiures or urinary incontinence.

Abstract: An electrophotographic image bearing unit including a belt-form electrophotographic photoreceptor including an electroconductive substrate and a photosensitive layer located overlying the substrate and optionally a protective layer located overlying the photosensitive layer; and a pressing member which presses the photoreceptor while a surface of the pressing member contacts a surface of the photosensitive layer side of the photoreceptor such that the photoreceptor has a U-form portion, wherein the pressing member is rotated by the photoreceptor, wherein the surface of the photosensitive layer side of the photoreceptor has a static friction coefficient less than a static friction coefficient of the surface of the pressing member.